AU8479498A - Dual specificity phosphatase and methods of use - Google Patents

Dual specificity phosphatase and methods of use

Info

Publication number
AU8479498A
AU8479498A AU84794/98A AU8479498A AU8479498A AU 8479498 A AU8479498 A AU 8479498A AU 84794/98 A AU84794/98 A AU 84794/98A AU 8479498 A AU8479498 A AU 8479498A AU 8479498 A AU8479498 A AU 8479498A
Authority
AU
Australia
Prior art keywords
methods
use
dual specificity
specificity phosphatase
phosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU84794/98A
Inventor
Michael P. Myers
Nicholas K. Tonks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cold Spring Harbor Laboratory
Original Assignee
Cold Spring Harbor Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5190897P priority Critical
Priority to US60051908 priority
Priority to US9098498P priority
Priority to US60090984 priority
Application filed by Cold Spring Harbor Laboratory filed Critical Cold Spring Harbor Laboratory
Priority to PCT/US1998/014205 priority patent/WO1999002704A2/en
Publication of AU8479498A publication Critical patent/AU8479498A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU84794/98A 1997-07-08 1998-07-08 Dual specificity phosphatase and methods of use Abandoned AU8479498A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US5190897P true 1997-07-08 1997-07-08
US60051908 1997-07-08
US9098498P true 1998-06-29 1998-06-29
US60090984 1998-06-29
PCT/US1998/014205 WO1999002704A2 (en) 1997-07-08 1998-07-08 Dual specifically phosphatase and methods of use

Publications (1)

Publication Number Publication Date
AU8479498A true AU8479498A (en) 1999-02-08

Family

ID=26729940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84794/98A Abandoned AU8479498A (en) 1997-07-08 1998-07-08 Dual specificity phosphatase and methods of use

Country Status (2)

Country Link
AU (1) AU8479498A (en)
WO (1) WO1999002704A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248327B1 (en) 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
WO2000060092A2 (en) * 1999-04-07 2000-10-12 Ceptyr, Inc. Dsp-3 dual-specificity phosphatase
WO2001002581A1 (en) * 1999-07-02 2001-01-11 Ceptyr, Inc. Dsp-3 dual-specificity phosphatase
US7078210B2 (en) 1999-07-02 2006-07-18 Ceptyr, Inc. DSP-3 dual-specificity phosphatase
US6284538B1 (en) 1999-07-21 2001-09-04 Isis Pharmaceuticals, Inc. Antisense inhibition of PTEN expression
AU6903800A (en) * 1999-08-13 2001-03-13 Sugen, Inc. Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders
EP1268818A2 (en) 2000-03-24 2003-01-02 Millennium Pharmaceuticals, Inc. 18221, dual specificity phosphatase and uses thereof
WO2001091699A2 (en) * 2000-05-30 2001-12-06 Advanced Research & Technology Institute Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
AU2003291736A1 (en) * 2002-11-05 2004-06-03 Cell Signaling Technology, Inc. Methods and materials for examining pathways associated with glioblastoma progression
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004074459A2 (en) * 2003-02-19 2004-09-02 Georgetown University Pten-deficient cells and their uses
CA2777628A1 (en) 2009-10-16 2011-04-21 The University Of British Columbia Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990067011A (en) * 1995-10-23 1999-08-16 임페리얼 캔서 리서치 테크놀로지 리미티드 Diagnostic sensitivity and their treatment for cancer
US6262242B1 (en) * 1997-01-30 2001-07-17 Board Of Regents, The University Of Texas System Tumor suppressor designated TS10Q23.3
CA2280097A1 (en) * 1997-02-07 1998-08-13 The Trustees Of Columbia University In The City Of New York Use of the p-ten suppressor gene in diagnosis and treatment of cancer

Also Published As

Publication number Publication date
WO1999002704A2 (en) 1999-01-21
WO1999002704A3 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU738907C (en) Dinucleotides and their use
AU6701598A (en) Inhibitors of impdh enzyme
HK1003935A1 (en) Enzyme inhibitors
AU6073296A (en) Salt-stabilized enzyme preparations
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
AU7595696A (en) Liposomal compositions and methods of using them
IL133927D0 (en) Manufacture of alpha-olefins
AU9599498A (en) Biosensor
AU1916899A (en) Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
AU6684394A (en) Improvements relating to the lining of pipelines and passageways
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2653495A (en) The cytoplasmic inhibition of gene expression
PL189698B1 (en) Water-soluble promedicines of paklitaxel
AU3847997A (en) Inhibitors of the interaction between P53 and MDM2
AU1676999A (en) Ultrasonography of the prostate
AU9509498A (en) Perfusion-occlusion catheter and methods
IL138027A (en) Intermediates for the preparation of metalloproteinase inhibitors and their preparation
HU9603475D0 (en) Inhibitors of interlaukin-1beta converting enzyme
AU6034296A (en) Tricyclic inhibitors of protein farnesyltransferase
EP1009415A4 (en) INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR
AU2884695A (en) Modified pseudomonas lipases and their use
AU2884595A (en) Modified pseudomonas lipases and their use
AU5250098A (en) Chemical functionalization of surfaces
PL336235A1 (en) Liquid enzymatic preparation and application thereof
AU7167298A (en) Inhibitors of the jnk signal transduction pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase